Aktis Oncology, Inc.
AKTS
$21.62
-$0.03-0.14%
NASDAQ
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Net Income | -12.06M | ||||
| Total Depreciation and Amortization | 441.00K | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | -617.00K | ||||
| Change in Net Operating Assets | -567.00K | ||||
| Cash from Operations | -12.80M | ||||
| Capital Expenditure | -2.23M | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -170.65M | ||||
| Cash from Investing | -172.88M | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | 65.00K | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | 0.00 | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -1.87M | ||||
| Cash from Financing | -1.80M | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -187.49M | ||||